A Look Inside the Silos: Where Healthcare Innovations Mature in a Protected Environment

The closer a technology comes to the human body, the less room there is for error. This is especially true for implants. Before a new sensor or material can be implanted in the body, years of research, testing, and optimization have gone into it. This is precisely why specialized development facilities are needed.

One example is implantable pressure sensors that can be attached directly to osteosynthetic metal implants. There, they measure the mechanical stress in the area of a bone fracture. If this stress changes, conclusions can be drawn about stability and the healing process. In the future, this could enable doctors to detect earlier whether healing is proceeding as expected or if complications are looming.

The technology is already more advanced than one might expect: corresponding sensor systems are currently undergoing clinical trials and have already been used in humans for the first time.

However, before reaching this point, problems must be solved that are scarcely visible outside this highly specialized field. How can a sensor in the body be continuously powered? How does it transmit data to the outside world? And how can we prevent this very connection from becoming a security risk? Some sensor systems can be operated passively via NFC and powered from an external source. At the same time, data transmission creates new cybersecurity requirements.

The value of the technological protection space lies precisely in this depth: A single solution must simultaneously be medically sound, technically reliable, biocompatible, energy-efficient, and secure. Only when these questions have been adequately answered can the door toward clinical application be opened further.

The situation is similar with bioresorbable implants. Fixation elements made of magnesium can stabilize a bone during healing and subsequently degrade within the body. This eliminates the need for a second surgery to remove the implant.

What sounds simple is highly complex from a materials science perspective. The implant must neither lose its stability too early nor remain in place for an unnecessarily long time. Its composition, porosity, surface structure, and geometry all influence its degradation. Additive manufacturing and AI-driven optimization open up new possibilities for specifically coordinating these factors. This is precisely where we see why a silo can be valuable at first: Specialization creates the depth necessary to even make a technology ready for the next step. Dr. Harald Unterweger, deputy director of the Health Innovation Network at Bayern Innovativ, summarizes: “Over the next five to ten years, I expect progress primarily on the sensor technology front: more continuous measurements, better trend data, and closer monitoring of therapies. Therapeutic actuators will follow, but at a slower pace. The path involves small, well-grounded steps—and in my view, that is precisely the right approach.”

However, this protected environment must not become a permanent state. At the latest when moving toward medical device status, additional perspectives are needed—from clinical practice, regulatory approval, production, and the market. Specialized research must evolve into a solution that can stand up to the realities of everyday healthcare delivery.

The Technology Transfer Center (TTZ) in Stein also has a specialized space of this kind—though it is dedicated to entirely different technologies.

The TTZ for Digitalization in Emergency Medical Education focuses on how digital technologies can be used to prepare people for situations in which medical decisions must be made within a very short time.

This involves the use of virtual and augmented reality, artificial intelligence, smart applications, healthcare data analytics, and machine learning.

Here, the term “safe space” has a very concrete meaning: virtual scenarios can be used to recreate medical emergencies that would be nearly impossible to train for in a predictable way in real life. Complex situations can be repeated, modified, and then analyzed—without putting patients at risk.

In a research project, for example, the TTZ is investigating how immersive emergency scenarios affect teaching and what impact they have on confidence in taking action and the quality of decisions. At the same time, data is being generated that can be used to analyze decision-making processes and, in the future, tailor training programs more individually.

This controlled environment thus enables something that would be virtually impossible in real-world healthcare settings: testing new technologies, analyzing mistakes and decisions, and gaining insights before an approach is implemented in practice.

Another project demonstrates just how relevant this expertise can become outside the research environment. Together with partners in Ukraine, the TTZ is working to optimize triage processes in emergency rooms. The focus is on how digital decision support can help, especially in high-pressure situations. Companies can also access the center’s specialized expertise and infrastructure—from technical consulting and prototype development to medical studies and regulatory validation.

The safe space remains intact. But the knowledge built up within it is now connecting with the outside world.

Smart implants and digital emergency simulations could hardly be more different from a technological standpoint. What they have in common, however, is that their development benefits from highly specialized facilities.

In the case of implants, materials science, sensor technology, and medicine can address problems that must be solved before a technology is introduced into the human body. In digital emergency medicine, new approaches can be tested without using real patients as test subjects.

The value of such silos thus lies not in their isolation, but in the protection they offer: they create space for specialization, experimentation, and expertise.

They become a risk where the door remains closed. When clinical partners are lacking, companies cannot access research, or technologies work but fail to make their way into clinical care and the market, protection turns into isolation.

The decisive moment, therefore, is the transition: When is a technology ready enough to leave its protective space—and who helps it find the right partners and applications out there?

It’s precisely this look inside the silos that’s worthwhile. Because there, technologies may be waiting that hardly anyone outside a small specialist community knows about yet.